Pharmaceutical giant Purdue Pharma has filed for Chapter 11 bankruptcy as part of a tentative agreement to settle thousands of lawsuits over its role in the opioid crisis.
The company responsible for OxyContin announced Sunday it filed for bankruptcy protections just days after agreeing to terms with state attorneys general in over 2,000 lawsuits that claim Purdue’s blockbuster drug was behind the epidemic of opioid addiction.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
